VCYT NASDAQ
Veracyte, Inc.
1W: +10.1%
1M: +6.1%
3M: -13.4%
YTD: +13.7%
1Y: +35.2%
3Y: +131.8%
5Y: +6.8%
$50.28
+2.08 (+4.32%)
After Hours: $50.75 (+0.47, +0.94%)
Weekly Expected Move ±6.8%
$41
$45
$48
$51
$54
Credit Risk of going bust: lower than 72% of companies Debt: 1.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.07 (down 99.9%), Veracyte, Inc. would be worth roughly what it owes.
Total debt $40.1M against a stock market value of $3.87B.
Distance to default 8.00 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $20.1M (short-term plus half of long-term), stock volatility 64.2%; Altman Z'' 16.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.07 (down 99.9%), Veracyte, Inc. would be worth roughly what it owes.
Total debt $40.1M against a stock market value of $3.87B.
Distance to default 8.00 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $20.1M (short-term plus half of long-term), stock volatility 64.2%; Altman Z'' 16.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.67
Bullish
3 bullish
1 neutral
0 bearish
Articles (7d)
4
Daily Sentiment (7 Days)
Articles (100)
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Gibbs Wealth Management Acquires New Holdings in Veracyte, Inc. $VCYT
Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Veracyte (NASDAQ:VCYT) Stock Price Breaks Below 200 Day Moving Average – Should You Sell?
Natera Gains 118.1% in a Year: What's Driving the Rally?
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms
Cathie Wood’s Ark weekly recap: cuts SpaceX exposure alongside HOOD, TER, boosts CRWV, VCYT
Veracyte, Inc. (NASDAQ:VCYT) Stock Has Average Target Price of $55.78
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Is it the Right Time to Add Phibro Stock to Your Portfolio?
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
Bruker Gains 66.3% in a Year: What's Driving the Rally?
Veracyte (NASDAQ:VCYT) Shares Down 4.3% – Here’s Why
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
Reasons to Add Globus Medical Stock to Your Portfolio Now
Charles River Gains 75.8% in a Year: What's Driving the Rally?
Is This the Right Time to Add TMO Stock to Your Portfolio?
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Cathie Wood's Ark Invest weekly recap: loads up on Nvidia, Intellia; pares AMD
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises
Should You Continue to Hold IART Stock in Your Portfolio?
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
Here's Why You Should Retain BDX Stock in Your Portfolio for Now
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Should You Continue to Hold IDXX Stock in Your Portfolio?
Veracyte (NASDAQ:VCYT) Insider John Leite Sells 4,015 Shares
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure
Is This the Right Time to Add DGX Stock to Your Portfolio?
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan
OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?
Squarepoint Ops LLC Sells 49,301 Shares of Veracyte, Inc. $VCYT
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Beta Bionics Stock Surges on FDA Clearance for Mint Patch Pump
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX
IDEXX Stock Gains Following the Acquisition of CoVet
Corient Private Wealth LP Has $9.52 Million Holdings in Veracyte, Inc. $VCYT
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
ISRG's da Vinci Study Shows Better Outcomes Across 13 Common Conditions
Should Investors Add EYE Stock to Their Portfolios Now?
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
Veracyte acquiring Convergent Genomics in up to $180M deal
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser
Should You Continue to Hold ALGN Stock in Your Portfolio?
Concurrent Investment Advisors LLC Takes Position in Veracyte, Inc. $VCYT
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
IceCure Secures China NMPA Approval for ProSense Cryoablation System
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down
Is This the Right Time to Add Neogen Stock to Your Portfolio?
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance
Abbott Receives FDA Nod for TactiFlex Duo: Stock to Gain?
3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes
The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?